Wikipedia:Articles for deletion/Atossa Therapeutics

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was delete. Consensus that it doesn't meet NCORP Nosebagbear (talk) 15:48, 14 May 2021 (UTC)[reply]

Atossa Therapeutics (edit | talk | history | protect | delete | links | watch | logs | views) – (View log)

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Restored WP:PROD. Does not appear to pass WP:GNG or WP:NCORP. This source may pass GNG. The others are stats pages, press releases, or less than significant coverage. WP:BEFORE not turning up additional GNG passing sources. –Novem Linguae (talk) 11:08, 7 May 2021 (UTC)[reply]

Note: This discussion has been included in the list of Companies-related deletion discussions. –Novem Linguae (talk) 11:08, 7 May 2021 (UTC)[reply]

Note: This discussion has been included in the list of United States of America-related deletion discussions. –Novem Linguae (talk) 11:08, 7 May 2021 (UTC)[reply]

Note: This discussion has been included in the list of Washington-related deletion discussions. Spiderone^{(Talk to Spider)} 18:41, 7 May 2021 (UTC)[reply]

• Delete: The article had been cleaned of some previous promotional text, but I am seeing just the description of a company going about its business, supported by routine coverage. The Simply Wall St posting mentioned in the nomination, I think falls short of the requirements of WP:CORPDEPTH. Such coverage as I'm seeing is more about testing of their Endoxifen product (any coverage of which should fall under medical considerations here), but I am not seeing the level of company-specific coverage needed for WP:NCORP. AllyD (talk) 06:22, 14 May 2021 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.